ATE270891T1 - Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma - Google Patents

Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma

Info

Publication number
ATE270891T1
ATE270891T1 AT99967434T AT99967434T ATE270891T1 AT E270891 T1 ATE270891 T1 AT E270891T1 AT 99967434 T AT99967434 T AT 99967434T AT 99967434 T AT99967434 T AT 99967434T AT E270891 T1 ATE270891 T1 AT E270891T1
Authority
AT
Austria
Prior art keywords
neospora
toxoplasma
treatment
diseases caused
triazinone compounds
Prior art date
Application number
AT99967434T
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE270891T1 publication Critical patent/ATE270891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99967434T 1998-12-22 1999-12-18 Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma ATE270891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,713 US6194408B1 (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
PCT/US1999/030293 WO2000037064A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
ATE270891T1 true ATE270891T1 (de) 2004-07-15

Family

ID=22816196

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967434T ATE270891T1 (de) 1998-12-22 1999-12-18 Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma

Country Status (16)

Country Link
US (1) US6194408B1 (de)
EP (1) EP1140102B1 (de)
JP (1) JP4806121B2 (de)
KR (1) KR100661102B1 (de)
CN (1) CN1188128C (de)
AT (1) ATE270891T1 (de)
AU (1) AU770108B2 (de)
BR (1) BR9916432A (de)
CA (1) CA2356151C (de)
DE (1) DE69918716T2 (de)
ES (1) ES2226492T3 (de)
HU (1) HU228994B1 (de)
NZ (1) NZ512478A (de)
PT (1) PT1140102E (de)
WO (1) WO2000037064A2 (de)
ZA (1) ZA200104205B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469987B1 (en) 1998-01-13 2002-10-22 Enterasys Networks, Inc. Virtual local area network with trunk stations
AU766542B2 (en) * 1998-10-08 2003-10-16 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
EP1276499A2 (de) * 2000-04-25 2003-01-22 Wyeth Impstoff gegen protozoen myoenzephalitis vor pferden
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
US6562007B1 (en) * 2000-09-28 2003-05-13 Bayer Healthcare Llc Adjustable dosage syringe
BRPI0406795A (pt) * 2003-01-16 2006-01-17 Janssen Pharmaceutica Nv Composições antiprotozoários que compreendem diclazuril
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101148098B1 (ko) * 2010-04-30 2012-05-22 한국화학연구원 1-［4-（4-니트로-페녹시）-페닐］-프로판-1-온을 유효성분으로 함유하는 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료용 조성물
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
WO2020093014A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2313721A1 (de) * 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
AU616916B2 (en) 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones

Also Published As

Publication number Publication date
CN1331594A (zh) 2002-01-16
JP4806121B2 (ja) 2011-11-02
ES2226492T3 (es) 2005-03-16
KR20010087412A (ko) 2001-09-15
CA2356151A1 (en) 2000-06-29
WO2000037064A2 (en) 2000-06-29
HUP0104710A3 (en) 2003-10-28
JP2002532545A (ja) 2002-10-02
HUP0104710A2 (hu) 2002-04-29
EP1140102A2 (de) 2001-10-10
AU2370900A (en) 2000-07-12
AU770108B2 (en) 2004-02-12
ZA200104205B (en) 2002-05-22
CA2356151C (en) 2009-02-24
EP1140102B1 (de) 2004-07-14
BR9916432A (pt) 2001-09-04
CN1188128C (zh) 2005-02-09
HU228994B1 (en) 2013-07-29
HK1043315A1 (en) 2002-09-13
PT1140102E (pt) 2004-10-29
DE69918716T2 (de) 2005-08-04
US6194408B1 (en) 2001-02-27
NZ512478A (en) 2003-07-25
KR100661102B1 (ko) 2006-12-26
DE69918716D1 (de) 2004-08-19
WO2000037064A3 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
DE69918716D1 (de) Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE303162T1 (de) Natrium kanalblocker zusammensetzungen und deren verwendung
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
NO990912D0 (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
DE60036456D1 (de) Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
GB0130677D0 (en) Medicaments and novel compounds
BR9808221A (pt) Método de tratamento de tumor.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
PT1056458E (pt) Tratamento de dor cronica
DE60115237D1 (de) Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
LV12459A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140102

Country of ref document: EP